Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Quality of life in Polish patients with multiple sclerosis.
Gelsolin decreases actin toxicity and inflammation in murine multiple sclerosis.
Multiple Sclerosis and Risk of Infection-Related Hospitalization and Death in US Veterans.
Using conceptual work products of case management to design health IT.
Clinical Feasibility of Synthetic MRI in Multiple Sclerosis: A Diagnostic and Volumetric Validation Study.
Cannabinoid modulation of neuroinflammatory disorders.
Your client has multiple sclerosis: understanding the challenge.
Vitamin A: yet another player in multiple sclerosis pathogenesis?
Effect of high-dose vitamin d3 intake on ambulation, muscular pain and bone mineral density in a woman with multiple sclerosis: a 10-year longitudinal case report.
[The clinical outcomes of idiopathic optic neuritis with no light perception in 21 eyes].
If I had clinically isolated syndrome with magnetic resonance imaging diagnostic of multiple sclerosis, I would take vitamin D 10,000 IU daily: Yes.
Medicinal cannabis.
Laquinimod in the treatment of multiple sclerosis: a review of the data so far.
The P66Shc/Mitochondrial Permeability Transition Pore Pathway Determines Neurodegeneration.
Interaction between the protective effects of cannabidiol and palmitoylethanolamide in experimental model of multiple sclerosis in C57BL/6 mice.
Traumatic fatal cerebral hemorrhage in an old patient with a history of multiple sclerosis under dabigatran: a case report and review of the literature.
Increasing consistency of disease biomarker prediction across datasets.
Cerebrospinal fluid ferritin-Unspecific and unsuitable for disease monitoring.
Preferences of Patients With Multiple Sclerosis for Attributes of Disease Modifying Drugs In Decision-Making: A Nominal Group Technique And Best-Worst Scaling.
The poor recovery of neuromyelitis optica spectrum disorder is associated with a lower level of CXCL12 in the human brain.
B cell-directed therapies in multiple sclerosis.
Agent based modeling of the effects of potential treatments over the blood-brain barrier in multiple sclerosis.
Rituximab in treatment-resistant CIDP with antibodies against paranodal proteins.
HIV immunodynamics and multiple sclerosis.
Decreased regenerative capacity of oligodendrocyte progenitor cells (NG2-glia) in the ageing brain: a vicious cycle of synaptic dysfunction, myelin loss and neuronal disruption?

Pages